Darine Ghanem: Shaping the Future of Hemophilia A Care Together at ISTH 2026
Darine Ghanem, Commercialisation Excellence Lead for Non-Malignant Hemathology at Roche, shared on LinkedIn:
“Every generation has the opportunity and the responsibility to leave hemophilia A care better than they found it.
As we gather at International Society on Thrombosis and Haemostasis (ISTH), I am inspired by how far our community has come and energized by what we can achieve together.
Scientific progress continues to redefine what is possible, but our ambition remains unchanged: to keep listening to the community, to keep learning, to keep innovating, and to continue elevating the standard of care for people living with hemophilia around the world.
Here for Generations. Here for Life. This is our enduring commitment to patients, families, healthcare professionals, and the broader hemophilia A community that we will continue to lead with purpose, advance innovation, and work together to create a better future.
I want to extend my sincere thanks to all our Roche teams across all affiliates and to our Pharma CEO Teresa Harris Graham and to our Head of Pharma International Padraic Ward for being with us at ISTH in Paris this year.
Your leadership, expertise, and unwavering commitment to the hemophilia A community are what make this progress possible. Every day, you bring our purpose to life through collaboration, scientific excellence, and an enduring focus on improving patients’ lives.
I am grateful to the conversations, learning, and partnerships that ISTH inspired. Together, we have the opportunity to shape the future of hemophilia A care for generations to come, and for life.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 15:06Elisa Rossi: Advancing HHT Research at the 16th International Conference
-
Oct 18, 2026, 14:58Aishwarya Dash: Simplifying Bone Marrow Mesenchymal Stromal Cell Isolation
-
Oct 18, 2026, 14:54Caitlin Raymond: Could the Apheresis Circuit Itself Modulate Immunity?
-
Oct 18, 2026, 13:0810 Posts Not to Miss This Week
-
Oct 18, 2026, 12:58Pierpaolo Di Micco: DOACs vs Vitamin K Antagonists in Long-Term Anticoagulation
-
Oct 18, 2026, 12:51Arianne Missimer: Understanding Ferritin Levels Beyond the Normal Range
-
Oct 18, 2026, 12:37Roberto C. Iglesias: Colon Cancer Prevention Beyond Supplements and Vitamins
-
Oct 18, 2026, 12:27Rafael Alejandro Camero Del Vecchio: Paroxysmal Nocturnal Hemoglobinuria Advancing Complement Inhibition with Ravulizumab
-
Oct 18, 2026, 12:26Abdul Mannan: When INR Misleads – Rethinking Bleeding Risk in Cirrhosis